Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapy

Leukemia, 2018 - nature.com
Adaptive resistance mediated by inhibitory ligands such as PD-L1 has emerged as an
important mechanism of malignant cell survival and spurred the development of new agents …
被引用次数：64 相关文章
[HTML] sciencedirect.com

[HTML][HTML] Oncolytic Reovirus Sensitizes Multiple Myeloma Cells to Anti-PD-L1 Therapy

KR Kelly, CM Espitia, W Zhao, K Wu, V Visconte… - Blood, 2017 - Elsevier
Adaptive resistance mediated by inhibitory ligands such as programmed death 1 ligand (PD-
L1) has emerged as an important mechanism of malignant cell survival. This has spurred the …

Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapy.

KR Kelly, CM Espitia, W Zhao, K Wu, V Visconte… - Leukemia, 2017 - europepmc.org
Adaptive resistance mediated by inhibitory ligands such as PD-L1 has emerged as an
important mechanism of malignant cell survival and spurred the development of new agents …

Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapy

KR Kelly, CM Espitia, W Zhao, K Wu, V Visconte… - Leukemia, 2018 - go.gale.com
Adaptive resistance mediated by inhibitory ligands such as PD-L1 has emerged as an
important mechanism of malignant cell survival and spurred the development of new agents …

[引用][C] Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapy

KR Kelly, CM Espitia, W Zhao, K Wu, V Visconte… - Leukemia, 2017 - cir.nii.ac.jp

Oncolytic Reovirus Sensitizes Multiple Myeloma Cells to Anti-PD-L1 Therapy

KR Kelly, CM Espitia, W Zhao, K Wu, V Visconte… - Blood, 2017 - ashpublications.org
Adaptive resistance mediated by inhibitory ligands such as programmed death 1 ligand (PD-
L1) has emerged as an important mechanism of malignant cell survival. This has spurred the …
[HTML] nih.gov

[HTML][HTML] Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapy

KR Kelly, CM Espitia, W Zhao, K Wu, V Visconte… - Leukemia, 2018 - ncbi.nlm.nih.gov
Adaptive resistance mediated by inhibitory ligands such as PD-L1 has emerged as an
important mechanism of malignant cell survival and spurred the development of new agents …

[引用][C] Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapy

KR Kelly, CM Espitia, W Zhao, K Wu… - …, 2018 - pubmed.ncbi.nlm.nih.gov
Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapy Oncolytic reovirus
sensitizes multiple myeloma cells to anti-PD-L1 therapy Leukemia. 2018 Jan;32(1):230-233 …